ID   ROCK1_HUMAN             Reviewed;        1354 AA.
AC   Q13464; B0YJ91; Q2KHM4; Q59GZ4;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-NOV-2010, entry version 111.
DE   RecName: Full=Rho-associated protein kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Renal carcinoma antigen NY-REN-35;
DE   AltName: Full=Rho-associated, coiled-coil-containing protein kinase 1;
DE   AltName: Full=p160 ROCK-1;
DE            Short=p160ROCK;
GN   Name=ROCK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 187-195; 281-288;
RP   465-473; 818-828; 885-893 AND 934-945, FUNCTION, PHOSPHORYLATION,
RP   INTERACTION WITH RHOA, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Leukemia;
RX   MEDLINE=96203110; PubMed=8617235;
RA   Ishizaki T., Maekawa M., Fujisawa K., Okawa K., Iwamatsu A.,
RA   Fujita A., Watanabe N., Saito Y., Kakizuka A., Morii N., Narumiya S.;
RT   "The small GTP-binding protein Rho binds to and activates a 160 kDa
RT   Ser/Thr protein kinase homologous to myotonic dystrophy kinase.";
RL   EMBO J. 15:1885-1893(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-13; 85-94; 327-334; 405-415 AND 546-563,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Ramsay A., Leung H.Y.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 323-1027.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   ROLE IN SMOOTH MUSCLE CONTRACTION.
RX   PubMed=9722579; DOI=10.1074/jbc.273.36.23433;
RA   Van Eyk J.E., Arrell D.K., Foster D.B., Strauss J.D., Heinonen T.Y.,
RA   Furmaniak-Kazmierczak E., Cote G.P., Mak A.S.;
RT   "Different molecular mechanisms for Rho family GTPase-dependent, Ca2+-
RT   independent contraction of smooth muscle.";
RL   J. Biol. Chem. 273:23433-23439(1998).
RN   [7]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   MEDLINE=99438124; PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [8]
RP   INTERACTION WITH PPP1R12A.
RX   PubMed=10579722; DOI=10.1083/jcb.147.5.1023;
RA   Kawano Y., Fukata Y., Oshiro N., Amano M., Nakamura T., Ito M.,
RA   Matsumura F., Inagaki M., Kaibuchi K.;
RT   "Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase
RT   by Rho-kinase in vivo.";
RL   J. Cell Biol. 147:1023-1038(1999).
RN   [9]
RP   FUNCTION, INTERACTION WITH LIMK1 AND LIMK2, AND INHIBITION BY Y-27632.
RX   PubMed=10436159; DOI=10.1126/science.285.5429.895;
RA   Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A.,
RA   Obinata T., Ohashi K., Mizuno K., Narumiya S.;
RT   "Signaling from Rho to the actin cytoskeleton through protein kinases
RT   ROCK and LIM-kinase.";
RL   Science 285:895-898(1999).
RN   [10]
RP   INTERACTION WITH LIMK2.
RX   PubMed=11018042; DOI=10.1074/jbc.M007074200;
RA   Sumi T., Matsumoto K., Nakamura T.;
RT   "Specific activation of LIM kinase 2 via phosphorylation of threonine
RT   505 by ROCK, a Rho-dependent protein kinase.";
RL   J. Biol. Chem. 276:670-676(2001).
RN   [11]
RP   CLEAVAGE BY CASPASE-3, MUTAGENESIS OF ASP-1113, INTERACTION WITH
RP   PPP1R12A, AND FUNCTION.
RX   MEDLINE=21180369; PubMed=11283607; DOI=10.1038/35070019;
RA   Sebbagh M., Renvoize C., Hamelin J., Riche N., Bertoglio J.,
RA   Breard J.;
RT   "Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and
RT   apoptotic membrane blebbing.";
RL   Nat. Cell Biol. 3:346-352(2001).
RN   [12]
RP   INTERACTION WITH RHOE AND PPP1R12A, AND SUBCELLULAR LOCATION.
RX   MEDLINE=22658517; PubMed=12773565;
RX   DOI=10.1128/MCB.23.12.4219-4229.2003;
RA   Riento K., Guasch R.M., Garg R., Jin B., Ridley A.J.;
RT   "RhoE binds to ROCK I and inhibits downstream signaling.";
RL   Mol. Cell. Biol. 23:4219-4229(2003).
RN   [13]
RP   REVIEW.
RX   PubMed=12778124; DOI=10.1038/nrm1128;
RA   Riento K., Ridley A.J.;
RT   "Rocks: multifunctional kinases in cell behaviour.";
RL   Nat. Rev. Mol. Cell Biol. 4:446-456(2003).
RN   [14]
RP   INTERACTION WITH TSG101.
RX   PubMed=17853893; DOI=10.1038/sj.emboj.7601850;
RA   Morita E., Sandrin V., Chung H.Y., Morham S.G., Gygi S.P.,
RA   Rodesch C.K., Sundquist W.I.;
RT   "Human ESCRT and ALIX proteins interact with proteins of the midbody
RT   and function in cytokinesis.";
RL   EMBO J. 26:4215-4227(2007).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH DAPK3.
RX   PubMed=17158456; DOI=10.1074/jbc.M609990200;
RA   Hagerty L., Weitzel D.H., Chambers J., Fortner C.N., Brush M.H.,
RA   Loiselle D., Hosoya H., Haystead T.A.;
RT   "ROCK1 phosphorylates and activates zipper-interacting protein
RT   kinase.";
RL   J. Biol. Chem. 282:4884-4893(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1180, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-455 AND SER-456, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1105, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1105, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-647, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 947-1015 IN COMPLEX WITH
RP   RHOA.
RX   PubMed=14660612; DOI=10.1074/jbc.M311911200;
RA   Dvorsky R., Blumenstein L., Vetter I.R., Ahmadian M.R.;
RT   "Structural insights into the interaction of ROCKI with the switch
RT   regions of RhoA.";
RL   J. Biol. Chem. 279:7098-7104(2004).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-108; SER-773; PRO-1112; SER-1193;
RP   GLU-1217; GLN-1262 AND ARG-1264.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates and activates DAPK3, which then regulates
CC       myosin light chain phosphatase through phosphorylation of MYPT1
CC       thereby regulating the assembly of the actin cytoskeleton, cell
CC       migration, invasiveness of tumor cells, smooth muscle contraction
CC       and neurite outgrowth. Required for centromere positioning and
CC       centromere-dependent exit from mitosis. Necessary for apoptotic
CC       membrane blebbing.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by RHOA binding. Inhibited by Y-
CC       27632.
CC   -!- SUBUNIT: Binds RHOA (activated by GTP). Interacts with ADD1, GEM,
CC       RHOB, RHOC, MYL12B and VIM (By similarity). Binds RHOE, PPP1R12A,
CC       LIMK1 and LIMK2. Interacts with TSG101. Interacts with DAPK3.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-876651, EBI-876651;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton,
CC       centrosome, centriole (By similarity). Golgi apparatus membrane;
CC       Peripheral membrane protein. Note=Associated with the mother
CC       centriole and an intercentriolar linker (By similarity). A small
CC       proportion is associated with Golgi membranes.
CC   -!- TISSUE SPECIFICITY: Detected in blood platelets.
CC   -!- DOMAIN: The C-terminal auto-inhibitory domain interferes with
CC       kinase activity. RHOA binding leads to a conformation change and
CC       activation of the kinase. Truncated ROCK1 is constitutively
CC       activated.
CC   -!- PTM: Autophosphorylated on serine and threonine residues.
CC       Phosphorylated upon DNA damage, probably by ATM or ATR.
CC   -!- PTM: Cleaved by caspase-3 during apoptosis. This leads to
CC       constitutive activation of the kinase and membrane blebbing.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 PH domain.
CC   -!- SIMILARITY: Contains 1 phorbol-ester/DAG-type zinc finger.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 REM (Hr1) repeat.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U43195; AAB02814.1; -; mRNA.
DR   EMBL; EF445027; ACA06069.1; -; Genomic_DNA.
DR   EMBL; BC113114; AAI13115.1; -; mRNA.
DR   EMBL; AB208965; BAD92202.1; -; mRNA.
DR   IPI; IPI00022542; -.
DR   PIR; S69211; S69211.
DR   RefSeq; NP_005397.1; -.
DR   UniGene; Hs.306307; -.
DR   PDB; 1S1C; X-ray; 2.60 A; X/Y=946-1015.
DR   PDB; 2ESM; X-ray; 3.20 A; A/B=6-415.
DR   PDB; 2ETK; X-ray; 2.96 A; A/B=6-415.
DR   PDB; 2ETR; X-ray; 2.60 A; A/B=6-415.
DR   PDB; 2V55; X-ray; 3.70 A; A/C=1-406.
DR   PDB; 3D9V; X-ray; 3.30 A; A/B=6-415.
DR   PDBsum; 1S1C; -.
DR   PDBsum; 2ESM; -.
DR   PDBsum; 2ETK; -.
DR   PDBsum; 2ETR; -.
DR   PDBsum; 2V55; -.
DR   PDBsum; 3D9V; -.
DR   ProteinModelPortal; Q13464; -.
DR   SMR; Q13464; 1119-1204, 1205-1288.
DR   IntAct; Q13464; 3.
DR   MINT; MINT-1195170; -.
DR   STRING; Q13464; -.
DR   PhosphoSite; Q13464; -.
DR   PRIDE; Q13464; -.
DR   Ensembl; ENST00000399799; ENSP00000382697; ENSG00000067900.
DR   GeneID; 6093; -.
DR   KEGG; hsa:6093; -.
DR   UCSC; uc002kte.1; human.
DR   CTD; 6093; -.
DR   GeneCards; GC18M018529; -.
DR   H-InvDB; HIX0014355; -.
DR   HGNC; HGNC:10251; ROCK1.
DR   HPA; CAB004562; -.
DR   HPA; HPA007567; -.
DR   MIM; 601702; gene.
DR   PharmGKB; PA34623; -.
DR   eggNOG; prNOG12593; -.
DR   HOGENOM; HBG445047; -.
DR   HOVERGEN; HBG053111; -.
DR   InParanoid; Q13464; -.
DR   OMA; KGEEETF; -.
DR   OrthoDB; EOG9GQSQW; -.
DR   PhylomeDB; Q13464; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; amb2_neutrophils_pathway; amb2 Integrin signaling.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; ephbfwdpathway; EPHB forward signaling.
DR   Pathway_Interaction_DB; avb3_integrin_pathway; Integrins in angiogenesis.
DR   Pathway_Interaction_DB; prlsignalingeventspathway; Signaling events mediated by PRL.
DR   Pathway_Interaction_DB; vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_578; Apoptosis.
DR   BindingDB; Q13464; -.
DR   NextBio; 23695; -.
DR   ArrayExpress; Q13464; -.
DR   Bgee; Q13464; -.
DR   CleanEx; HS_ROCK1; -.
DR   Genevestigator; Q13464; -.
DR   GO; GO:0005814; C:centriole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0000910; P:cytokinesis; IEA:InterPro.
DR   GO; GO:0050901; P:leukocyte tethering or rolling; IDA:BHF-UCL.
DR   GO; GO:0022614; P:membrane to membrane docking; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0007266; P:Rho protein signal transduction; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000861; HR1_rpt_rho-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_type.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR001849; Pleckstrin_homology.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR020684; Rho-assoc_coiled-coil_kin-like.
DR   InterPro; IPR015751; Rho-assoc_coiled-coil_kinase.
DR   InterPro; IPR015008; Rho-bd.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 2.
DR   Gene3D; G3DSA:1.20.5.730; Rho_bd; 1.
DR   PANTHER; PTHR22988:SF3; Rho_kinase; 1.
DR   Pfam; PF02185; HR1; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   Pfam; PF08912; Rho_Binding; 1.
DR   PIRSF; PIRSF037568; Rho_kinase; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; FALSE_NEG.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Apoptosis; ATP-binding; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Golgi apparatus; Kinase; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2   1354       Rho-associated protein kinase 1.
FT                                /FTId=PRO_0000086619.
FT   DOMAIN       76    338       Protein kinase.
FT   DOMAIN      341    409       AGC-kinase C-terminal.
FT   REPEAT      458    542       REM.
FT   DOMAIN     1118   1317       PH.
FT   NP_BIND      82     90       ATP (By similarity).
FT   ZN_FING    1228   1281       Phorbol-ester/DAG-type.
FT   REGION      998   1010       RHOA binding.
FT   REGION     1115   1354       Auto-inhibitory.
FT   COILED      422    612       Potential.
FT   COILED     1011   1102       Potential.
FT   COMPBIAS    636    980       Glu-rich.
FT   ACT_SITE    198    198       Proton acceptor (By similarity).
FT   BINDING     105    105       ATP (By similarity).
FT   SITE       1113   1114       Cleavage; by caspase-3.
FT   MOD_RES       2      2       N-acetylserine.
FT   MOD_RES     455    455       Phosphothreonine.
FT   MOD_RES     456    456       Phosphoserine.
FT   MOD_RES     647    647       N6-acetyllysine.
FT   MOD_RES    1105   1105       Phosphoserine.
FT   MOD_RES    1180   1180       Phosphothreonine.
FT   VARIANT     108    108       S -> N (in dbSNP:rs55811609).
FT                                /FTId=VAR_041055.
FT   VARIANT     773    773       T -> S (in dbSNP:rs45562542).
FT                                /FTId=VAR_041056.
FT   VARIANT    1112   1112       T -> P (in dbSNP:rs35881519).
FT                                /FTId=VAR_041057.
FT   VARIANT    1193   1193       P -> S (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041058.
FT   VARIANT    1217   1217       Q -> E.
FT                                /FTId=VAR_041059.
FT   VARIANT    1262   1262       R -> Q.
FT                                /FTId=VAR_041060.
FT   VARIANT    1264   1264       C -> R.
FT                                /FTId=VAR_041061.
FT   MUTAGEN    1113   1113       D->A: Abolishes cleavage by caspase-3.
FT   CONFLICT    170    170       V -> A (in Ref. 3; AAI13115).
FT   CONFLICT    197    197       R -> G (in Ref. 3; AAI13115).
FT   CONFLICT    220    220       C -> R (in Ref. 3; AAI13115).
FT   CONFLICT    323    325       RLG -> GTR (in Ref. 5; BAD92202).
FT   CONFLICT    521    521       D -> N (in Ref. 3; AAI13115).
FT   CONFLICT    965    965       K -> R (in Ref. 3; AAI13115).
FT   CONFLICT   1354   1354       S -> R (in Ref. 2; ACA06069).
FT   HELIX         7     19
FT   HELIX        27     39
FT   HELIX        44     47
FT   HELIX        50     69
FT   HELIX        73     75
FT   STRAND       76     83
FT   STRAND       90     95
FT   TURN         96     98
FT   STRAND      101    108
FT   HELIX       109    113
FT   HELIX       121    130
FT   STRAND      139    144
FT   STRAND      146    153
FT   HELIX       161    167
FT   HELIX       172    191
FT   TURN        201    203
FT   STRAND      204    206
FT   STRAND      212    214
FT   TURN        238    240
FT   HELIX       243    247
FT   HELIX       258    273
FT   HELIX       283    291
FT   HELIX       293    296
FT   HELIX       307    316
FT   HELIX       320    322
FT   TURN        324    327
FT   HELIX       330    333
FT   HELIX       336    338
FT   HELIX       345    350
FT   HELIX       392    394
FT   STRAND      399    402
FT   HELIX       947    982
FT   HELIX       984   1011
SQ   SEQUENCE   1354 AA;  158175 MW;  93078CBB009A6F27 CRC64;
     MSTGDSFETR FEKMDNLLRD PKSEVNSDCL LDGLDALVYD LDFPALRKNK NIDNFLSRYK
     DTINKIRDLR MKAEDYEVVK VIGRGAFGEV QLVRHKSTRK VYAMKLLSKF EMIKRSDSAF
     FWEERDIMAF ANSPWVVQLF YAFQDDRYLY MVMEYMPGGD LVNLMSNYDV PEKWARFYTA
     EVVLALDAIH SMGFIHRDVK PDNMLLDKSG HLKLADFGTC MKMNKEGMVR CDTAVGTPDY
     ISPEVLKSQG GDGYYGRECD WWSVGVFLYE MLVGDTPFYA DSLVGTYSKI MNHKNSLTFP
     DDNDISKEAK NLICAFLTDR EVRLGRNGVE EIKRHLFFKN DQWAWETLRD TVAPVVPDLS
     SDIDTSNFDD LEEDKGEEET FPIPKAFVGN QLPFVGFTYY SNRRYLSSAN PNDNRTSSNA
     DKSLQESLQK TIYKLEEQLH NEMQLKDEME QKCRTSNIKL DKIMKELDEE GNQRRNLEST
     VSQIEKEKML LQHRINEYQR KAEQENEKRR NVENEVSTLK DQLEDLKKVS QNSQLANEKL
     SQLQKQLEEA NDLLRTESDT AVRLRKSHTE MSKSISQLES LNRELQERNR ILENSKSQTD
     KDYYQLQAIL EAERRDRGHD SEMIGDLQAR ITSLQEEVKH LKHNLEKVEG ERKEAQDMLN
     HSEKEKNNLE IDLNYKLKSL QQRLEQEVNE HKVTKARLTD KHQSIEEAKS VAMCEMEKKL
     KEEREAREKA ENRVVQIEKQ CSMLDVDLKQ SQQKLEHLTG NKERMEDEVK NLTLQLEQES
     NKRLLLQNEL KTQAFEADNL KGLEKQMKQE INTLLEAKRL LEFELAQLTK QYRGNEGQMR
     ELQDQLEAEQ YFSTLYKTQV KELKEEIEEK NRENLKKIQE LQNEKETLAT QLDLAETKAE
     SEQLARGLLE EQYFELTQES KKAASRNRQE ITDKDHTVSR LEEANSMLTK DIEILRRENE
     ELTEKMKKAE EEYKLEKEEE ISNLKAAFEK NINTERTLKT QAVNKLAEIM NRKDFKIDRK
     KANTQDLRKK EKENRKLQLE LNQEREKFNQ MVVKHQKELN DMQAQLVEEC AHRNELQMQL
     ASKESDIEQL RAKLLDLSDS TSVASFPSAD ETDGNLPESR IEGWLSVPNR GNIKRYGWKK
     QYVVVSSKKI LFYNDEQDKE QSNPSMVLDI DKLFHVRPVT QGDVYRAETE EIPKIFQILY
     ANEGECRKDV EMEPVQQAEK TNFQNHKGHE FIPTLYHFPA NCDACAKPLW HVFKPPPALE
     CRRCHVKCHR DHLDKKEDLI CPCKVSYDVT SARDMLLLAC SQDEQKKWVT HLVKKIPKNP
     PSGFVRASPR TLSTRSTANQ SFRKVVKNTS GKTS
//
